MicroRNA analysis: Is it ready for prime time?

Clinical Chemistry

Volumn 59, Issue 2, 2013, Pages 343-347

  Tsongalis, Gregory J ^a   Calin, George ^b   Cordelier, Pierre ^c,d,e   Croce, Carlo ^f,g   Monzon, Federico ^h,i   Szafranska Schwarzbach, Anna E ^j  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d CANCER RESEARCH CENTER OF TOULOUSE   (France)

^e UNIVERSITÉ PAUL SABATIER   (France)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ TEXAS CHILDREN S HOSPITAL   (United States)

^j ASURAGEN INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 15A; MICRORNA 210; MICRORNA 221; PROTEIN BCL 2; PROTEIN MCL 1;

BODY FLUID; CANCER SCREENING; CARCINOGENESIS; CELL FUNCTION; CELL LINEAGE; CHRONIC PANCREATITIS; CLONAL VARIATION; FALSE NEGATIVE RESULT; GENE EXPRESSION; IN SITU HYBRIDIZATION; LUNG LAVAGE; NOTE; PANCREAS ADENOCARCINOMA; PERSONALIZED MEDICINE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; MICRORNAS; NEOPLASMS; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84873159174     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.185009     Document Type: Note

References (0)